ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
1 story in the last 7 days
The latest alzheimers news, distilled by AI into sharp ~100-word summaries. ByteBrief tracks alzheimers across dozens of tech sources and brings you only what matters, updated hourly. Tap any story for the full brief, or open the original source.

PANDA Therapeutics secured €160,000 (CHF 150,000) from Venture Kick to advance its first-in-class antibody-based Alzheimer's therapy toward clinical development. The therapy targets multiple harmful protein deposits, including amyloid-beta and tau, simultaneously. Founded by CEO Hui Zhang, the startup aims to slow disease progression more broadly than current antibody treatments.
Summaries by ByteBrief